US 10316031
Compositions and methods for inhibiting kinases
granted A61KA61K2300/00A61K31/506
Quick answer
US patent 10316031 (Compositions and methods for inhibiting kinases) held by Inhibikase Therapeutics, Inc. expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibikase Therapeutics, Inc.
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2300/00, A61K31/506, A61K45/06, A61P